$NLNK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LUMOS PHARMA, INC.. Get notifications about new insider transactions in LUMOS PHARMA, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 05 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 500 | 1,050 | 65,739 | |
Dec 05 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 20.96 | 449 | 9,410 | 6,413 | 6.9 K to 6.4 K (-6.54 %) |
Dec 05 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 20.96 | 51 | 1,069 | 6,862 | 6.9 K to 6.9 K (-0.74 %) |
Dec 05 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 500 | 1,050 | 6,913 | 6.4 K to 6.9 K (+7.80 %) |
Dec 04 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 22.14 | 20,000 | 442,800 | 849,487 | 869.5 K to 849.5 K (-2.30 %) |
Dec 02 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.19 | 30,000 | 665,760 | 69,144 | 99.1 K to 69.1 K (-30.26 %) |
Dec 02 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.07 | 7,500 | 165,556 | 99,144 | 106.6 K to 99.1 K (-7.03 %) |
Dec 02 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 22.16 | 4,500 | 99,720 | 106,644 | 111.1 K to 106.6 K (-4.05 %) |
Nov 20 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 18.04 | 3,800 | 68,536 | 111,144 | 114.9 K to 111.1 K (-3.31 %) |
Nov 20 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 18.06 | 2,200 | 39,725 | 114,944 | 117.1 K to 114.9 K (-1.88 %) |
Nov 20 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.04 | 7,500 | 135,269 | 869,487 | 877 K to 869.5 K (-0.86 %) |
Nov 20 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.06 | 4,500 | 81,257 | 876,987 | 881.5 K to 877 K (-0.51 %) |
Nov 05 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 18.03 | 4,000 | 72,100 | 117,144 | 121.1 K to 117.1 K (-3.30 %) |
Nov 05 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 17.28 | 8,000 | 138,200 | 121,144 | 129.1 K to 121.1 K (-6.19 %) |
Nov 07 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.03 | 8,000 | 144,200 | 881,487 | 889.5 K to 881.5 K (-0.90 %) |
Oct 01 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 19.34 | 20,000 | 386,800 | 889,487 | 909.5 K to 889.5 K (-2.20 %) |
Oct 01 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.29 | 20,000 | 365,800 | 909,487 | 929.5 K to 909.5 K (-2.15 %) |
Aug 07 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.13 | 6,600 | 119,658 | 929,487 | 936.1 K to 929.5 K (-0.71 %) |
Aug 05 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.08 | 8,400 | 151,872 | 936,087 | 944.5 K to 936.1 K (-0.89 %) |
Aug 05 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.13 | 5,000 | 90,650 | 944,487 | 949.5 K to 944.5 K (-0.53 %) |
Jul 02 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 7,000 | 0 | 10,000 | 17 K to 10 K (-41.18 %) |
Jul 02 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 7,000 | 0 | 17,000 | 10 K to 17 K (+70.00 %) |
Jul 02 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 20.34 | 20,000 | 406,800 | 949,487 | 969.5 K to 949.5 K (-2.06 %) |
Jul 02 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 14,000 | 0 | 969,487 | 983.5 K to 969.5 K (-1.42 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 2.10 | 952 | 1,999 | 0 | |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 2.10 | 2,380 | 4,998 | 0 | |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 2.10 | 2,380 | 4,998 | 0 | |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 2.10 | 19,047 | 39,999 | 0 | |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 19.51 | 22,094 | 431,054 | 25,513 | 47.6 K to 25.5 K (-46.41 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Payment of Exercise | F | 19.51 | 2,665 | 51,994 | 47,607 | 50.3 K to 47.6 K (-5.30 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 2.10 | 24,759 | 51,994 | 50,272 | 25.5 K to 50.3 K (+97.04 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 19.90 | 20,000 | 398,000 | 129,144 | 149.1 K to 129.1 K (-13.41 %) |
Jun 07 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 19.03 | 25,000 | 475,750 | 983,487 | 1 M to 983.5 K (-2.48 %) |
Jun 07 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 17.52 | 25,000 | 438,000 | 1,008,487 | 1 M to 1 M (-2.42 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 10,500 | 22,050 | 66,239 | |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 20.00 | 9,397 | 187,940 | 6,413 | 15.8 K to 6.4 K (-59.44 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 20.00 | 1,103 | 22,060 | 15,810 | 16.9 K to 15.8 K (-6.52 %) |
Jun 12 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 10,500 | 22,050 | 16,913 | 6.4 K to 16.9 K (+163.73 %) |
May 24 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 800 | 1,680 | 76,739 | |
May 24 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 15.67 | 692 | 10,844 | 6,413 | 7.1 K to 6.4 K (-9.74 %) |
May 24 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 15.67 | 108 | 1,692 | 7,105 | 7.2 K to 7.1 K (-1.50 %) |
May 24 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 800 | 1,680 | 7,213 | 6.4 K to 7.2 K (+12.47 %) |
Jun 04 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 16.40 | 15,000 | 246,000 | 1,033,487 | 1 M to 1 M (-1.43 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 14.96 | 35,000 | 523,600 | 1,048,487 | 1.1 M to 1 M (-3.23 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 14.58 | 40,000 | 583,200 | 1,083,487 | 1.1 M to 1.1 M (-3.56 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 3,200 | 6,720 | 77,539 | |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 14.65 | 2,741 | 40,156 | 6,413 | 9.2 K to 6.4 K (-29.94 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 14.65 | 459 | 6,724 | 9,154 | 9.6 K to 9.2 K (-4.77 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 3,200 | 6,720 | 9,613 | 6.4 K to 9.6 K (+49.90 %) |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
May 10 2013 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
Apr 05 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 11.74 | 15,000 | 176,100 | 1,123,487 | 1.1 M to 1.1 M (-1.32 %) |
Apr 05 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 11.92 | 5,000 | 59,600 | 1,138,487 | 1.1 M to 1.1 M (-0.44 %) |
Apr 05 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 11.99 | 55,000 | 659,450 | 1,143,487 | 1.2 M to 1.1 M (-4.59 %) |
Feb 05 2013 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Buy | P | 11.40 | 880,000 | 10,032,000 | 7,077,245 | 6.2 M to 7.1 M (+14.20 %) |
Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | A | 11.79 | 30,000 | 353,700 | 30,000 | |
Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | A | 11.79 | 36,000 | 424,440 | 36,000 | |
Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 11.79 | 204,000 | 2,405,160 | 204,000 | |
Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 11.79 | 90,000 | 1,061,100 | 90,000 | |
Jan 16 2013 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 11.79 | 155,000 | 1,827,450 | 155,000 | |
Jan 04 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 1,000 | 2,100 | 80,739 | |
Jan 04 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 12.10 | 826 | 9,993 | 4,313 | 5.1 K to 4.3 K (-16.07 %) |
Jan 04 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 12.10 | 174 | 2,105 | 5,139 | 5.3 K to 5.1 K (-3.27 %) |
Jan 04 2013 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 1,000 | 2,100 | 5,313 | 4.3 K to 5.3 K (+23.19 %) |
Dec 19 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 12.50 | 25,000 | 312,500 | 1,198,487 | 1.2 M to 1.2 M (-2.04 %) |
Nov 30 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 1,000 | 2,100 | 81,739 | |
Nov 30 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 12.53 | 832 | 10,422 | 4,313 | 5.1 K to 4.3 K (-16.17 %) |
Nov 30 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 12.53 | 168 | 2,104 | 5,145 | 5.3 K to 5.1 K (-3.16 %) |
Nov 30 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 1,000 | 2,100 | 5,313 | 4.3 K to 5.3 K (+23.19 %) |
Nov 06 2012 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | A | 13.30 | 11,902 | 158,297 | 11,902 | |
Nov 06 2012 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 13.30 | 17,855 | 237,472 | 17,855 | |
Nov 06 2012 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 13.30 | 9,522 | 126,643 | 9,522 | |
Nov 06 2012 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 13.30 | 11,902 | 158,297 | 11,902 | |
Nov 02 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 1,000 | 2,100 | 82,739 | |
Nov 02 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 13.77 | 847 | 11,661 | 4,313 | 5.2 K to 4.3 K (-16.41 %) |
Nov 02 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 13.77 | 153 | 2,106 | 5,160 | 5.3 K to 5.2 K (-2.88 %) |
Nov 02 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 1,000 | 2,100 | 5,313 | 4.3 K to 5.3 K (+23.19 %) |
Oct 17 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 5,500 | 11,550 | 0 | |
Oct 17 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 14.84 | 4,721 | 70,065 | 4,313 | 9 K to 4.3 K (-52.26 %) |
Oct 17 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 14.84 | 779 | 11,561 | 9,034 | 9.8 K to 9 K (-7.94 %) |
Oct 17 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 5,500 | 11,550 | 9,813 | 4.3 K to 9.8 K (+127.52 %) |
Aug 30 2012 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | M | 0.53 | 2,380 | 1,261 | 0 | |
Aug 30 2012 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | M | 0.53 | 2,380 | 1,261 | 23,380 | 21 K to 23.4 K (+11.33 %) |
Jul 30 2012 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | Pres and Chief Medi ... | Option Exercise | M | 2.10 | 12,772 | 26,821 | 0 | |
Jul 30 2012 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | Pres and Chief Medi ... | Option Exercise | M | 4.20 | 17,623 | 74,017 | 0 | |
Jul 30 2012 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | Pres and Chief Medi ... | Buy | M | 2.10 | 12,772 | 26,821 | 149,144 | 136.4 K to 149.1 K (+9.37 %) |
Jul 30 2012 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | Pres and Chief Medi ... | Buy | M | 4.20 | 17,623 | 74,017 | 136,372 | 118.7 K to 136.4 K (+14.84 %) |
Jul 23 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Buy | P | 13.54 | 139 | 1,882 | 139 | 0 to 139 |
Jun 22 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 15.12 | 48,000 | 725,760 | 1,223,487 | 1.3 M to 1.2 M (-3.78 %) |
Jun 22 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 15.92 | 102,000 | 1,623,840 | 1,271,487 | 1.4 M to 1.3 M (-7.43 %) |
Jun 22 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 22 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 10,000 | 0 | 1,373,487 | 1.4 M to 1.4 M (-0.72 %) |
Jun 22 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 13,000 | 0 | 1,383,487 | 1.4 M to 1.4 M (-0.93 %) |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 0.80 | 3,500 | 2,800 | 0 | |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | M | 2.10 | 6,000 | 12,600 | 0 | |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 0.80 | 3,500 | 2,800 | 3,500 | 0 to 3.5 K |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Sell | S | 15.49 | 5,187 | 80,347 | 0 | 5.2 K to 0 (-100.00 %) |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Payment of Exercise | F | 15.49 | 813 | 12,593 | 5,187 | 6 K to 5.2 K (-13.55 %) |
Jun 21 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Buy | M | 2.10 | 6,000 | 12,600 | 6,000 | 0 to 6 K |
Mar 07 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | M | 3.07 | 26,190 | 80,403 | 0 | |
Mar 07 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | M | 3.07 | 26,190 | 80,403 | 45,236 | 19 K to 45.2 K (+137.51 %) |
Mar 05 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | M | 2.10 | 7,142 | 14,998 | 0 | |
Mar 05 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | M | 2.10 | 11,904 | 24,998 | 0 | |
Mar 05 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | M | 2.10 | 7,142 | 14,998 | 19,046 | 11.9 K to 19 K (+60.00 %) |
Mar 05 2012 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | M | 2.10 | 11,904 | 24,998 | 11,904 | 0 to 11.9 K |
Feb 17 2012 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | J | 0.00 | 1,737 | 0 | 23,714 | 22 K to 23.7 K (+7.90 %) |
Feb 17 2012 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | J | 0.00 | 977 | 0 | 21,977 | 21 K to 22 K (+4.65 %) |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 6.87 | 2,381 | 16,357 | 2,381 | |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 6.87 | 80,000 | 549,600 | 80,000 | |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Lynn Kenneth | Exec VP of Bus Deve ... | Option Exercise | A | 6.87 | 26,000 | 178,620 | 26,000 | |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | A | 6.87 | 26,000 | 178,620 | 26,000 | |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | LINK GORDON H JR | Chief Financial Off ... | Option Exercise | A | 6.87 | 36,000 | 247,320 | 36,000 | |
Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 6.87 | 140,000 | 961,800 | 140,000 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | C | 0.00 | 1,732 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Buy | C | 0.00 | 9,096 | 0 | 56,715 | 47.6 K to 56.7 K (+19.10 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | C | 0.00 | 1,732 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | C | 0.00 | 9,096 | 0 | 21,000 | 11.9 K to 21 K (+76.41 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | C | 0.00 | 13,856 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | C | 0.00 | 40,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | C | 0.00 | 72,772 | 0 | 118,749 | 46 K to 118.7 K (+158.28 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | C | 0.00 | 26,454 | 0 | 45,977 | 19.5 K to 46 K (+135.50 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | C | 0.00 | 51,960 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Buy | C | 0.00 | 272,898 | 0 | 1,396,487 | 1.1 M to 1.4 M (+24.29 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | C | 0.00 | 5,257 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | C | 0.00 | 19,999 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Option Exercise | C | 0.00 | 27,780 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Gift | G | 0.00 | 43,815 | 0 | 43,815 | 0 to 43.8 K |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Gift | G | 0.00 | 43,815 | 0 | 43,815 | 0 to 43.8 K |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Gift | G | 0.00 | 87,630 | 0 | 0 | 87.6 K to 0 (-100.00 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | P | 7.00 | 15,000 | 105,000 | 87,630 | 72.6 K to 87.6 K (+20.65 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | C | 0.00 | 27,609 | 0 | 72,630 | 45 K to 72.6 K (+61.32 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | C | 0.00 | 10,856 | 0 | 45,021 | 34.2 K to 45 K (+31.78 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | C | 0.00 | 9,523 | 0 | 34,165 | 24.6 K to 34.2 K (+38.65 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Lundquist David J. | Director | Buy | C | 0.00 | 13,267 | 0 | 24,642 | 11.4 K to 24.6 K (+116.63 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | C | 0.00 | 15,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Buy | C | 0.00 | 8,142 | 0 | 8,142 | 0 to 8.1 K |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Alexander Sarah | Director | Option Exercise | C | 0.00 | 1,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Alexander Sarah | Director | Option Exercise | C | 0.00 | 11,112 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Alexander Sarah | Director | Buy | C | 0.00 | 542 | 0 | 5,833 | 5.3 K to 5.8 K (+10.24 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Alexander Sarah | Director | Buy | C | 0.00 | 5,291 | 0 | 5,291 | 0 to 5.3 K |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Option Exercise | C | 0.00 | 320,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,760,000 | 0 | 0 | |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Buy | P | 7.00 | 2,142,857 | 14,999,999 | 6,197,245 | 4.1 M to 6.2 M (+52.85 %) |
Nov 18 2011 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Buy | C | 0.00 | 1,680,671 | 0 | 4,054,388 | 2.4 M to 4.1 M (+70.80 %) |